Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$17.77 -0.45 (-2.47%)
As of: Oct 2, 2026 · 12:32 PM EDT

Syndax Pharmaceuticals (SNDX) Non-Current Deffered Revenue (2015 - 2021)

Updated

Syndax Pharmaceuticals' Non-Current Deffered Revenue was $10.86 million in Q2 2021, down 12.3% from $12.38 million a year earlier and down 3.4% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Non-Current Deffered Revenue (2015 - 2021) Analysis & Trends

At the end of FY2020, Non-Current Deffered Revenue at Syndax Pharmaceuticals came in at $11.62 million, down 11.5% from FY2019.

  • Non-Current Deffered Revenue has now declined for three consecutive years, with a five-year compound annual growth rate of -5.5% (FY2015 to FY2020).
  • In earlier years, Non-Current Deffered Revenue was $13.13 million in FY2019 (-10.4%), $14.65 million in FY2018 (-12.6%), $16.76 million in FY2017 (+17.9%) and $14.22 million in FY2016 (-7.9%).
  • The Q2 2021 figure marks the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2015.
  • Compared with a year earlier, Non-Current Deffered Revenue has declined for 11 straight quarters, with an average decline of 11.1% over the last eight quarters.
  • The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q4 2017 (growth of 17.9%); the worst was Q4 2018 (a decline of 12.6%).
  • Per Business Quant data, SNDX's Non-Current Deffered Revenue in the three quarters before Q2 2021 was $11.24 million (Q1 2021), $11.62 million (Q4 2020) and $12 million (Q3 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Syndax Pharmaceuticals 1.68 Bn -53.94 Mn 69.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 10.86 Mn
Mar 31, 2021 11.24 Mn
Dec 31, 2020 11.62 Mn
Sep 30, 2020 12.00 Mn
Jun 30, 2020 12.38 Mn
Mar 31, 2020 12.75 Mn
Dec 31, 2019 13.13 Mn
Sep 30, 2019 13.51 Mn
Jun 30, 2019 13.89 Mn
Mar 31, 2019 14.27 Mn
Dec 31, 2018 14.65 Mn
Sep 30, 2018 15.03 Mn
Jun 30, 2018 15.41 Mn
Mar 31, 2018 15.79 Mn
Dec 31, 2017 16.76 Mn
Sep 30, 2017 13.31 Mn
Jun 30, 2017 13.61 Mn
Mar 31, 2017 13.92 Mn
Dec 31, 2016 14.22 Mn
Sep 30, 2016 14.53 Mn
API Access

Syndax Pharmaceuticals Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SNDX&period=max&api_key=YOUR_API_KEY